Haleon plc

HLN

$9.12

Name : Haleon plc

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $40,262,004,736.00

EPSttm : 0.51

Haleon plc

$9.12

2.59%

$0.23

HLN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.34

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

9.12

Target Price

11.3

Analyst Recom

1.94

Performance Q

-10.32

Upside

18.2%

Beta

0.13

Ticker: HLN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	HLN	8.98	0.09	0.82	3073
2026-05-12	HLN	9.1	0.09	0.13	3084
2026-05-13	HLN	9.02	0.09	8.00	3086
2026-05-14	HLN	8.92	0.09	0.28	3095
2026-05-15	HLN	8.95	0.09	0.64	3165
2026-05-18	HLN	9.16	0.28	0.00	945
2026-05-19	HLN	9.2	0.26	0.00	985
2026-05-20	HLN	9.27	0.26	0.02	988
2026-05-21	HLN	9.33	0.25	0.00	1023
2026-05-22	HLN	9.3	0.25	0.03	1035
2026-05-26	HLN	9.24	0.24	0.00	1062
2026-05-27	HLN	9.31	0.24	0.00	1063
2026-05-28	HLN	9.22	0.24	0.00	1063
2026-05-29	HLN	9.06	0.24	999.99	1068
2026-06-02	HLN	8.7	0.25	0.00	1092
2026-06-03	HLN	8.72	0.25	8.50	1093
2026-06-04	HLN	8.98	0.24	0.00	1089
2026-06-05	HLN	9.11	0.24	0.07	1092
2026-06-08	HLN	8.9	0.21	0.01	1217
2026-06-09	HLN	9.12	0.16	0.20	1552
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	HLN	8.98	-	-	-
2026-05-12	HLN	9.10	-	-	-
2026-05-13	HLN	9.02	-	-	-
2026-05-14	HLN	8.91	-	-	-
2026-05-15	HLN	8.95	-	-	-
2026-05-18	HLN	9.16	-	-	-
2026-05-19	HLN	9.19	-	-	-
2026-05-20	HLN	9.28	-	-	-
2026-05-21	HLN	9.32	-	-	-
2026-05-22	HLN	9.29	-	-	-
2026-05-26	HLN	9.24	-	-	-
2026-05-27	HLN	9.32	-	-	-
2026-05-28	HLN	9.22	-	-	-
2026-05-29	HLN	9.06	-	-	-
2026-06-01	HLN	8.83	-	-	-
2026-06-02	HLN	8.72	-	-	-
2026-06-03	HLN	8.72	-	-	-
2026-06-04	HLN	8.98	-	-	-
2026-06-05	HLN	9.10	-	-	-
2026-06-08	HLN	8.90	-	-	-
2026-06-09	HLN	9.12	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	HLN	0	1.11	0.28
2026-05-12	HLN	0	1.11	0.34
2026-05-13	HLN	0	1.11	0.34
2026-05-14	HLN	0	1.11	0.34
2026-05-15	HLN	0	1.11	0.34
2026-05-18	HLN	0	1.37	0.34
2026-05-19	HLN	0	1.37	0.34
2026-05-20	HLN	0	1.37	0.34
2026-05-21	HLN	0	1.37	0.34
2026-05-22	HLN	0	1.37	0.34
2026-05-26	HLN	0	0.68	0.34
2026-05-27	HLN	0	0.68	0.34
2026-05-28	HLN	0	0.68	0.34
2026-05-29	HLN	0	0.68	0.34
2026-06-02	HLN	0	-8.78	0.34
2026-06-03	HLN	0	-8.78	0.34
2026-06-04	HLN	0	-8.78	0.34
2026-06-05	HLN	0	-8.78	0.34
2026-06-08	HLN	0	-8.84	0.34
2026-06-09	HLN	0	-8.84	0.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-8.84

Beta

0.13

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

20.1

Max Drawdown 5-Year %

Target Price

11.3

P/E

18.72

Forward P/E

14.98

PEG

1.59

P/S

2.77

P/B

1.84

P/Free Cash Flow

14.95

EPS

0.49

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.12

Relative Volume

1.07

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ HLN Healthcare

$9.12

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

4/15

Valuation

15/20

TP/AR

1/10

Options

7/10

RSI

49.1

Range 1M

62.6%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

16/30

Estimates

0/20

Inst/Vol

1/15

Options

10/10

EPS Yr

9.3%

EPS NY

9.5%

52W%

17.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +25% upside

Quality

7/30

Valuation

6/30

Growth

11/25

Stability

4/10

LT Trend

1/5

Upside

+25%

Haleon plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 24535

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN

Latest News

—

Caricamento notizie per HLN…

stock quote shares HLN – Haleon plcHLN Stock Price stock today

news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025

marketwatch HLN – Haleon plcHLN yahoo finance google finance

stock history HLN – Haleon plcHLN invest stock market

stock prices HLN premarket after hours

ticker HLN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: HLN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y